Logo_AIHTA
  • English
            Menu_button
                                  Video
                                  Video: What is HTA?    
                                  • Home
                                  • News

                                  News

                                  Leiste32


                                  Welcome to the homepage of AIHTA!

                                  AIHTA is an academic non-profit institute. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the AIHTA team.

                                  In the News section you will find our most recent publications: newsletter, project-reports etc. Previous reports you might find via Research areas, Research projects and Repository.

                                  Subscribe to newsletter

                                  Newsletter_preview

                                  Newsletter

                                  Inhalt

                                  • Financing Personalized Medicine
                                  • HPV-Impfung
                                  • Bauchaortenaneurysmen
                                  • Physiotherapie nach Schlaganfall
                                  • Kapselendoskopie
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  HPV2

                                  Announcement

                                  Vaccination against human papillomavirus (HPV). Decision-aid for young women and girls

                                  In 2008 the German AOK-Bundesverband commissioned the LBI-HTA to develop a decision-aid on the vaccination against Human Papillomavirus (HPV) for young women and girls (online since June 2009). After smaller updates in 2010 and 2011, the updated, completely revised and partly new structured decision-aid went online in March 2015 (www.hpv-entscheidungshilfe.de).The first part of the decision aid contains information about the virus and HPV related diseases. The second part of the decision aid informs about the HPV-vaccine(s). Finally, the third part of the decision aid summarises information of parts I and II: eleven short information blocks can be rated according to the relevance for the decision (mainly pro or mainly contra vaccination or of no influence). In the present project report online contents are available in paper form for the first time. Hence, we were able to add country specific data for Austria and provide further, more detailed information (which has not been included in the online version due to complexity).

                                  Publication: Decision Support Document No. 79: https://eprints.aihta.at/1050

                                  Contact: Brigitte Piso

                                  More...

                                  2111

                                  Announcement

                                  Horizon Scanning in Onkology - Reports

                                  We are pleased to introduce our new HSO report.

                                  DSD HSO No. 50
                                  Nivolumab (Opdivo®) as single-agent first-line therapy for unresectable or metastatic melanoma

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Inhalt

                                  • Verschwendung im Gesundheitswesen
                                  • Intrakranielle Stents
                                  • Gesellschaftliche Präferenzen bei/für Refundierungsentscheidungen
                                  • Nicht invasive pränatale Tests für Trisomie 21
                                  • Advance Care Planning (ACP)
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  Lithuania

                                  Project / ,

                                  HTA Strategy for Lithuania

                                  Project leaders: /page/claudia-wild/en

                                  Project team: /page/claudia-wild/en, /page/tarquin-mittermayr/en

                                  Duration: February 2015 - July 2015
                                  Publication: HTA Decision Support Document No. 90a: https://eprints.aihta.at/1064/

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Inhalt

                                  • Anwendungsbeobachtungen
                                  • Hadronentherapie bei Kindern
                                  • Wochenbettbetreuung
                                  • Studien bei seltenen Erkrankungen
                                  • Screening auf Krebserkrankungen
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  Fotolia_59224653_S

                                  Announcement

                                  Hadron therapy in children: evidence synthesis for 15 paediatric tumours. Report based on Belgian (KCE) HTA report

                                  A Belgian KCE-Assessment analysed – as an update of the 2007 report –  the evidence for hadron therapy (proton and carbon ions) in 15 paediatric indications. Since 2015 the Austrian MedAustron started operating and the first patients are treated, the LBI -HTA has been involved in the Belgian report as external expert. Now the LBI -HTA wrote – due to the regional relevance – a German summary of the Belgian report.

                                  In the assessment 21 clinical studies (non-randomized, non-controlled and mostly retrospective) were found.  All studies showed serious methodological flaws. The conclusion therefore is that to date clinical data on PBT in all paediatric cancers under study are lacking as well as critical information on long-term effectiveness and harms.

                                  Prospective comparative clinical trials in the field are urgently needed.

                                  Publication: Decision Support Document Nr. 88: https://eprints.aihta.at/1049

                                  Contact: Claudia Wild

                                  More...

                                  Jahresbericht 2014

                                  Announcement

                                  Annual Report 2014 online

                                  Download PDF

                                  More...

                                  Fotolia_45417819_XS2

                                  Announcement

                                  Vasoprotectives: Efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoidal diseases

                                  The systematic review assessed the efficacy and safety of a treatment of chronic venous insufficiency (CVI) and haemorrhoidal diseases (HD) with capillary stabilising agents that are listed in the Austrian Code of Reimbursement.

                                  A total of 56 studies were included for a data synthesis.

                                  The majority of studies have shown that the symptoms and signs of CVI and HD can be reduced slightly with the agents (mostly when compared to placebo). Only minor side effects occurred.

                                  However, the strength of the evidence of nearly all identified studies is low. Therefore, we cannot draw a final conclusion on the efficacy of capillary stabilising agents for the treatment of CVI and HD.

                                  Publication: LBI-HTA Project report No. 79: https://eprints.aihta.at/1047

                                  Contact: Stefan Fischer

                                   

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Inhalt

                                  • Gründung des Forschungs- und Kompetenznetzwerkes Lebensende
                                  • Akupunktur
                                  • Magnetresonanztomographie
                                  • PET/Positronen-Emissions-Tomographie
                                  • Vasoprotektoren
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  « < ... 37 38 39 40 41 ... > »
                                  Displaying results 381 to 390.
                                                                                                      Netzwerk
                                                                                                      • Eunethta
                                                                                                      • Ebm
                                                                                                      • Inahta
                                                                                                      • Dexhelpp
                                                                                                      Shareholder
                                                                                                      • Bmfg
                                                                                                      • Sv
                                                                                                      • Wgfond
                                                                                                      • Noe
                                                                                                      • Ooghfond
                                                                                                      • Ghls
                                                                                                      • Tirol
                                                                                                      • Vorarlberg
                                                                                                      • Kghfond
                                                                                                      • Ghpf
                                                                                                      • Burgef
                                                                                                                © 2025 HTA Austria - Austrian Institute for Health Technology Assessment GmbH. Alle Rechte vorbehalten.
                                                                                                                • Log in